Anti-Cd20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2013.00502
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Frontiers Media SA